N-SIDE is very pleased to announce that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. With this new agreement, UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services to optimize the supply management from protocol design to ongoing clinical trials. Philippe Verlaine, Head of Clinical Supply Optimization at UCB, says :
With this implementation we seek to improve integration between UCB & N-SIDE solutions to leverage the respective specific capabilities and expertise to generate better demand forecasts. The Supply App, part of the N-SIDE Suite for Clinical Trials, offers improved collaboration support. Thus, this new application would be of substantial value for us by supporting the integration of UCB and N-SIDE teams in the simulation process flow.
As Jacques Parlongue, CEO at N-SIDE, states below, the integration of the N-SIDE optimization solution into UCB clinical supply strategy will allow them to minimize their drug waste from trial design to last patient out, while proactively managing the risk:
“We are proud to grow our collaboration with UCB as they implement the N-SIDE Suite of Clinical Trials. With the N-SIDE Suite for Clinical Trials, we can provide a new, efficient way of working together to reduce waste and optimize supply decisions throughout the management of clinical trials.”
To read the entire press release, click below to get the downloadable PDF version :